改良标准外伤大骨瓣开颅术治疗重型颅脑外伤的临床疗效评价

Improved Standard Trauma Big Bone Flap Craniotomy Surgery Clinical Curative Effect Evaluation for the Treatment of Severe Head Trauma

目的通过探究改良标准外伤大骨瓣开颅术的具体过程,了解其对重型颅脑外伤患者的治疗效果。方法方便选择在2006年2月—2015年12月进入医院进行治疗的重型颅脑外伤患者120例,将其平分为对比组和研究组。对比组患者使用标准外伤大骨瓣开颅术实施治疗,研究组则使用改良标准外伤大骨瓣开颅术的方法实施治疗,通过了解两者的区别,选出最佳的治疗方法。结果研究组的术后情况明显优于对比组,差异具有统计学意义(P<0.05);研究组的术后满意程度评分明显高于对比组,差异具有统计学意义(P<0.05);研究组患者的预后情况显著高于对比组,差异具有统计学意义(P<0.05)。研究组患者的两组术后并发症发生率显著低于于对比组,差异具有统计学意义(P<0.05)。结论在使用改良标准外伤大骨瓣开颅术之后,使得重型颅脑外伤患者的治疗效果明显提高,同时由于术后并发症较少,提高了患者的治疗满意程度,因此值得临床上提高推广使用。

Objective Through exploring modified concrete process of standard trauma big bone flap craniotomy surgery, understand its effect on the treatment of patients with severe craniocerebral injury. Methods Convenient selection from February 2006 to December 2015 in the hospital for treatment of 120 cases of patients with severe head injury, will be split into contrast group and the team. Control group using standard trauma patients with large bone flap craniotomy surgery treatment, the team is using method of modified trauma big bone flap craniotomy surgery treatment, by understanding the difference between the two, select the best treatment. Results The postoperative group is obviously better than the control group,with statistical significance（P〈0.05）; Team of postoperative satisfaction score is significantly higher than control group,with statistical significance（P〈0.05）; The team the prognosis of patients was significantly higher than control group, with statistical significance（P〈0.05）. The team in the two groups of patients with postoperative complication rate was significantly lower than in control group, with statistical significance（P〈0.05）. Conclusion In the use of improved standard trauma after big bone flap craniotomy surgery, making the treatment of patients with severe craniocerebral injury effect is improved obviously, at the same time because of less postoperative complications and improve the patient＇s satisfaction with treatment, therefore to improve clinical promotion use.